Anna C. Pavlick, MD | Authors

Articles

Ipilimumab Combined With Nivolumab for the Treatment of Patients With Melanoma

June 30, 2015

Anna C. Pavlick, MD, associate professor, co-director, Melanoma Program, assistant director, Clinical Research Education, discusses a study that examined two immunotherapy agents, ipilimumab and nivolumab, in patients with melanoma.